{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:12:51Z","timestamp":1789071171277,"version":"build-2803163510"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004951","name":"Ataturk University","doi-asserted-by":"publisher","award":["TDK-2022-10615"],"award-info":[{"award-number":["TDK-2022-10615"]}],"id":[{"id":"10.13039\/501100004951","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejphar.2026.179294","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T09:19:17Z","timestamp":1787390357000},"page":"179294","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Differential modulation of central sensitization pathways by common antipsychotics in a paclitaxel-induced neuropathic pain model"],"prefix":"10.1016","volume":"1033","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9104-0213","authenticated-orcid":false,"given":"Ay\u015fenur","family":"Budak Sava\u015f","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Ye\u015filyurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cemil","family":"Bayram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"\u00d6zkaraca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ufuk","family":"Okkay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selma","family":"Sezen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sel\u00e7uk","family":"\u015eenyayla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Hac\u0131m\u00fcft\u00fco\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.179294_bib1","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1111\/j.1460-9568.2005.04340.x","article-title":"Fyn kinase-mediated phosphorylation of NMDA receptor NR2B subunit at Tyr1472 is essential for maintenance of neuropathic pain","volume":"22","author":"Abe","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179294_bib2","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ejphar.2015.08.053","article-title":"The antipsychotic aripiprazole induces antinociceptive effects: possible role of peripheral dopamine D2 and serotonin 5-HT1A receptors","volume":"765","author":"Almeida-Santos","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179294_bib3","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/ejp.1140","article-title":"Assessment and manifestation of central sensitisation across different chronic pain conditions","volume":"22","author":"Arendt\u2010Nielsen","year":"2018","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.ejphar.2026.179294_bib4","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1111\/bph.13960","article-title":"Ameliorative effect of chlorpromazine hydrochloride on visceral hypersensitivity in rats: possible involvement of 5-HT2A receptor","volume":"174","author":"Asano","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179294_bib5","article-title":"Epidemiology of neuropathic pain: an analysis of prevalence and associated factors in UK Biobank","volume":"8","author":"Baskozos","year":"2023","journal-title":"Pain Rep"},{"key":"10.1016\/j.ejphar.2026.179294_bib6","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3389\/fphar.2019.00613","article-title":"Sigma-1 receptor inhibition reduces neuropathic pain induced by partial sciatic nerve transection in mice by opioid-dependent and -Independent mechanisms","volume":"10","author":"Bravo-Caparr\u00f3s","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179294_bib7","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1124\/jpet.102.033175","article-title":"Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors","volume":"302","author":"Burris","year":"2002","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2026.179294_bib8","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1038\/s41598-018-22217-9","article-title":"Critical role of sigma-1 receptors in central neuropathic pain-related behaviours after mild spinal cord injury in mice","volume":"8","author":"Castany","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2026.179294_bib9","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.161028","article-title":"Hevin\/Sparcl1 drives pathological pain through spinal cord astrocyte and NMDA receptor signaling","volume":"7","author":"Chen","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.ejphar.2026.179294_bib10","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.brainresbull.2014.06.003","article-title":"Dopaminergic modulation of neuropathic pain: Analgesia in rats by a D2-type receptor agonist","volume":"106","author":"Cobacho","year":"2014","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2026.179294_bib11","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1177\/87551225211004145","article-title":"Efficacy and safety considerations with second-generation antipsychotics as adjunctive analgesics: a review of literature","volume":"37","author":"Coronado","year":"2021","journal-title":"J. Pharm. Technol."},{"key":"10.1016\/j.ejphar.2026.179294_bib12","doi-asserted-by":"crossref","first-page":"336","DOI":"10.36311\/jhgd.v31.12228","article-title":"Use of psychotropic drugs in the treatment of fibromyalgia: a systematic review","volume":"31","author":"Costa","year":"2021","journal-title":"J. Human Growth Developm."},{"key":"10.1016\/j.ejphar.2026.179294_bib13","doi-asserted-by":"crossref","first-page":"186","DOI":"10.14336\/AD.2023.0515","article-title":"Targeting the JAK2\/STAT3 signaling pathway for chronic pain","volume":"15","author":"Dai","year":"2024","journal-title":"Aging Dis."},{"key":"10.1016\/j.ejphar.2026.179294_bib14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.neuint.2017.02.003","article-title":"Activation of the sigma-1 receptor by haloperidol metabolites facilitates brain-derived neurotrophic factor secretion from human astroglia","volume":"105","author":"Dalwadi","year":"2017","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejphar.2026.179294_bib15","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s40263-015-0278-3","article-title":"Update on the mechanism of action of aripiprazole: translational insights into antipsychotic strategies beyond dopamine receptor antagonism","volume":"29","author":"de Bartolomeis","year":"2015","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejphar.2026.179294_bib16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00213-009-1513-8","article-title":"Antagonism by haloperidol and its metabolites of mechanical hypersensitivity induced by intraplantar capsaicin in mice: role of sigma-1 receptors","volume":"205","author":"Entrena","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2026.179294_bib17","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/bcpt.12839","article-title":"Haloperidol decreases hyperalgesia and allodynia induced by chronic constriction injury","volume":"121","author":"Espinosa-Ju\u00e1rez","year":"2017","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2026.179294_bib18","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/2045125312451271","article-title":"Unexpected effect of aripiprazole on nociceptive pain","volume":"2","author":"Fei","year":"2012","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2026.179294_bib19","article-title":"Peripheral antinociception induced by aripiprazole is mediated by the opioid system","volume":"1\u20136","author":"Ferreira","year":"2017","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ejphar.2026.179294_bib20","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejphar.2026.179294_bib21","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1152\/physrev.00045.2019","article-title":"Neuropathic pain: from mechanisms to treatment","volume":"101","author":"Finnerup","year":"2021","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejphar.2026.179294_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/ejp.4755","article-title":"E-52862-A selective sigma-1 receptor antagonist, in peripheral neuropathic pain: two randomized, double-blind, phase 2 studies in patients with chronic postsurgical pain and painful diabetic neuropathy","volume":"29","author":"G\u00e1lvez","year":"2025","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.ejphar.2026.179294_bib23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0924-977X(00)00133-4","article-title":"D2 and 5HT2A receptor occupancy of different doses of quetiapine in schizophrenia: a PET study","volume":"11","author":"Gefvert","year":"2001","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2026.179294_bib24","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1007\/s10787-023-01293-y","article-title":"The effect of risperidone on behavioral reactions and gene expression of pro- and anti-inflammatory cytokines in neuropathic pain model induced by chronic constriction injury of the sciatic nerve in rat","volume":"31","author":"Haghighat Lari","year":"2023","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.ejphar.2026.179294_bib25","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/head.14091","article-title":"A prospective, randomized, double-blind trial of intravenous chlorpromazine versus intravenous prochlorperazine for the treatment of acute migraine in adults presenting to the emergency department","volume":"61","author":"Hodgson","year":"2021","journal-title":"Headache J. Head Face Pain"},{"key":"10.1016\/j.ejphar.2026.179294_bib26","doi-asserted-by":"crossref","first-page":"5642","DOI":"10.1111\/bph.15284","article-title":"Cytokine activin C ameliorates chronic neuropathic pain in peripheral nerve injury rodents by modulating the TRPV1 channel","volume":"177","author":"Huang","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179294_bib27","doi-asserted-by":"crossref","first-page":"350","DOI":"10.11607\/ofph.1317","article-title":"Pregabalin reduces acute inflammatory and persistent pain associated with nerve injury and cancer in rat models of orofacial pain","volume":"28","author":"Hummig","year":"2014","journal-title":"J. Oral Facial Pain Headache"},{"key":"10.1016\/j.ejphar.2026.179294_bib28","doi-asserted-by":"crossref","first-page":"4987","DOI":"10.3892\/mmr.2017.7185","article-title":"Sigma-1 receptor activation ameliorates anxiety-like behavior through NR2A-CREB-BDNF signaling pathway in a rat model submitted to single-prolonged stress","volume":"16","author":"Ji","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejphar.2026.179294_bib29","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.brainresrev.2008.12.011","article-title":"MAP kinase and pain","volume":"60","author":"Ji","year":"2009","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.ejphar.2026.179294_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107581","article-title":"Chemokines in chronic pain: cellular and molecular mechanisms and therapeutic potential","volume":"212","author":"Jiang","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2026.179294_bib31","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/AJP.0000000000000567","article-title":"A systematic review of atypical antipsychotics in chronic pain management: olanzapine demonstrates potential in central sensitization, fibromyalgia, and headache\/migraine","volume":"34","author":"Jimenez","year":"2018","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.ejphar.2026.179294_bib32","doi-asserted-by":"crossref","first-page":"8310","DOI":"10.1523\/JNEUROSCI.2396-04.2004","article-title":"Ionotropic and metabotropic receptors, protein kinase A, protein kinase C, and src contribute to C-Fiber-Induced ERK activation and cAMP response element-binding protein phosphorylation in dorsal horn neurons, leading to central sensitization","volume":"24","author":"Kawasaki","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179294_bib33","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1517\/13543784.12.4.655","article-title":"Aripiprazole: a partial dopamine D2 receptor agonist antipsychotic","volume":"12","author":"Keck Jr","year":"2003","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.ejphar.2026.179294_bib34","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/bjp.2008.159","article-title":"Activation of the spinal sigma-1 receptor enhances NMDA-induced pain via PKC- and PKA-dependent phosphorylation of the NR1 subunit in mice","volume":"154","author":"Kim","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179294_bib35","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.neuroscience.2016.06.057","article-title":"Antidepressants and gabapentinoids in neuropathic pain: mechanistic insights","volume":"338","author":"Kremer","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2026.179294_bib36","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.pharep.2015.01.017","article-title":"Effects of long-term treatment with the neuroleptics haloperidol, clozapine and olanzapine on immunoexpression of NMDA receptor subunits NR1, NR2A and NR2B in the rat hippocampus","volume":"67","author":"Krzystanek","year":"2015","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejphar.2026.179294_bib37","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/jnc.15693","article-title":"Specific detection and deletion of the sigma-1 receptor widely expressed in neurons and glial cells in vivo","volume":"164","author":"Liu","year":"2023","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2026.179294_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.999509","article-title":"NMDARs mediate peripheral and central sensitization contributing to chronic orofacial pain","volume":"16","author":"Liu","year":"2022","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179294_bib39","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/emj.2007.047860","article-title":"Chlorpromazine in migraine","volume":"24","author":"Loga","year":"2007","journal-title":"Emerg. Med. J."},{"key":"10.1016\/j.ejphar.2026.179294_bib40","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/art.38228","article-title":"Quetiapine fumarate extended\u2010release for the treatment of major depression with comorbid fibromyalgia syndrome: a double\u2010blind, randomized, placebo\u2010controlled study","volume":"66","author":"McIntyre","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.ejphar.2026.179294_bib41","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/fcp.12754","article-title":"Risperidone in analgesia induced by paracetamol and meloxicam in experimental pain","volume":"36","author":"Miranda","year":"2022","journal-title":"Fund. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179294_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2024.105612","article-title":"Is the central sensitization inventory (CSI) associated with quantitative sensory testing (QST)? A systematic review and meta-analysis","volume":"161","author":"Neblett","year":"2024","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2026.179294_bib43","doi-asserted-by":"crossref","first-page":"e383","DOI":"10.1016\/S2665-9913(21)00032-1","article-title":"Central sensitisation in chronic pain conditions: latest discoveries and their potential for precision medicine","volume":"3","author":"Nijs","year":"2021","journal-title":"Lancet Rheumatol."},{"key":"10.1016\/j.ejphar.2026.179294_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2025.110454","article-title":"Aripiprazole: the antiallodynic and antihyperalgesic effects in chronic constriction injury-induced neuropathic pain and reserpine-induced fibromyalgia with possible mechanisms","volume":"273","author":"Okcay","year":"2025","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2026.179294_bib45","doi-asserted-by":"crossref","first-page":"11325","DOI":"10.1523\/JNEUROSCI.0458-14.2014","article-title":"NMDA receptors are upregulated and trafficked to the plasma membrane after Sigma-1 receptor activation in the rat hippocampus","volume":"34","author":"Pabba","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179294_bib46","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.pnpbp.2012.10.025","article-title":"Clozapine regulation of p90RSK and c-Fos signaling via the ErbB1-ERK pathway is distinct from olanzapine and haloperidol in mouse cortex and striatum","volume":"40","author":"Pereira","year":"2013","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatr."},{"key":"10.1016\/j.ejphar.2026.179294_bib47","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/JCP.0b013e318267b8ca","article-title":"Add-on treatment of quetiapine for fibromyalgia: a pilot, randomized, double-blind, placebo-controlled 12-week trial","volume":"32","author":"Potvin","year":"2012","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2026.179294_bib48","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1097\/j.pain.0000000000001939","article-title":"The revised international association for the study of pain definition of pain: concepts, challenges, and compromises","volume":"161","author":"Raja","year":"2020","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2026.179294_bib49","first-page":"583","article-title":"Aripiprazole improves spinal cord injury in rats: involvement of inflammatory pathways","author":"Rismanbaf","year":"2022","journal-title":"Acta Med. Iran."},{"key":"10.1016\/j.ejphar.2026.179294_bib50","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.3390\/ph17081096","article-title":"Haloperidol for pain management: a narrative review","volume":"17","author":"Roldan","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejphar.2026.179294_bib51","doi-asserted-by":"crossref","first-page":"907","DOI":"10.3390\/jpm12060907","article-title":"Sex-related differences in pharmacological response to CNS drugs: a narrative review","volume":"12","author":"Romanescu","year":"2022","journal-title":"J. Personalized Med."},{"key":"10.1016\/j.ejphar.2026.179294_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2019.00862","article-title":"Neuronal Sigma-1 receptors: signaling functions and protective roles in neurodegenerative diseases","volume":"13","author":"Ryskamp","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179294_bib53","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.schres.2006.03.033","article-title":"Impact of haloperidol, a dopamine D2 antagonist, on cognition and mood","volume":"85","author":"Saeedi","year":"2006","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ejphar.2026.179294_bib54","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-3-319-50174-1_9","article-title":"Sigma-1 receptor antagonists: a new class of neuromodulatory analgesics","volume":"964","author":"S\u00e1nchez-Fern\u00e1ndez","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ejphar.2026.179294_bib55","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jpainsymman.2009.09.008","article-title":"Antipsychotics for acute and chronic pain in adults","volume":"39","author":"Seidel","year":"2010","journal-title":"J. Pain Symptom Manag."},{"key":"10.1016\/j.ejphar.2026.179294_bib56","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2174\/0115672026391315250822063941","article-title":"Anandamide as a therapeutic target for alleviating neuropathic pain and inflammation in rat models","volume":"22","author":"Sharma","year":"2025","journal-title":"Curr. Neurovascular Res."},{"key":"10.1016\/j.ejphar.2026.179294_bib57","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3344\/kjp.2018.32.1.3","article-title":"Antipsychotics for patients with pain","volume":"32","author":"Shin","year":"2019","journal-title":"Korean J. Pain"},{"key":"10.1016\/j.ejphar.2026.179294_bib58","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.3390\/jcm11113002","article-title":"Novel therapies for the treatment of neuropathic pain: potential and pitfalls","volume":"11","author":"Shinu","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ejphar.2026.179294_bib59","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3109\/09540261.2010.515965","article-title":"Gender differences in antipsychotic prescribing","volume":"22","author":"Smith","year":"2010","journal-title":"Int. Rev. Psychiatr."},{"key":"10.1016\/j.ejphar.2026.179294_bib60","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/nn.4053","article-title":"Different immune cells mediate mechanical pain hypersensitivity in male and female mice","volume":"18","author":"Sorge","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179294_bib61","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1177\/0269881113478281","article-title":"Comparison of the anti-dopamine D2 and anti-serotonin 5-HT2A activities of chlorpromazine, bromperidol, haloperidol and second-generation antipsychotics parent compounds and metabolites thereof","volume":"27","author":"Suzuki","year":"2013","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2026.179294_bib62","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.2147\/JPR.S329280","article-title":"Central sensitization in migraine: a narrative review","volume":"15","author":"Suzuki","year":"2022","journal-title":"J. Pain Res."},{"key":"10.1016\/j.ejphar.2026.179294_bib63","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.neuroscience.2007.09.014","article-title":"Protracted effects of chronic oral haloperidol and risperidone on nerve growth factor, cholinergic neurons, and spatial reference learning in rats","volume":"150","author":"Terry","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2026.179294_bib64","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.neuroscience.2007.03.003","article-title":"Oral haloperidol or risperidone treatment in rats: temporal effects on nerve growth factor receptors, cholinergic neurons, and memory performance","volume":"146","author":"Terry","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2026.179294_bib65","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.neuroscience.2008.08.030","article-title":"Negative effects of chronic oral chlorpromazine and olanzapine treatment on the performance of tasks designed to assess spatial learning and working memory in rats","volume":"156","author":"Terry","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2026.179294_bib66","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1007\/s00210-023-02568-5","article-title":"Parthenolide as a potential analgesic in the treatment of paclitaxel-induced neuropathic pain: the rat modeling","volume":"396","author":"Toraman","year":"2023","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.ejphar.2026.179294_bib67","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0304-3940(02)00034-4","article-title":"Quetiapine attenuates the immobilization stress-induced decrease of brain-derived neurotrophic factor expression in rat hippocampus","volume":"321","author":"Xu","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2026.179294_bib68","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejphar.2013.01.068","article-title":"Sigma 1 receptor: a new therapeutic target for pain","volume":"716","author":"Zamanillo","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179294_bib69","article-title":"5-HT1F receptor agonist ameliorates mechanical allodynia in neuropathic pain via induction of mitochondrial biogenesis and suppression of neuroinflammation","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179294_bib70","doi-asserted-by":"crossref","DOI":"10.1177\/17448069251333928","article-title":"PDCD4 inhibition alleviates neuropathic pain by regulating spinal autophagy and neuroinflammation","volume":"21","author":"Zhang","year":"2025","journal-title":"Mol. Pain"},{"key":"10.1016\/j.ejphar.2026.179294_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpain.2025.105457","article-title":"Engineered RVG-exosomes-mediated delivery of siRNAs targeting NMDAR alleviates orofacial neuropathic pain by suppressing central sensitivity","volume":"33","author":"Zhang","year":"2025","journal-title":"J. Pain"},{"key":"10.1016\/j.ejphar.2026.179294_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2025.106404","article-title":"Spinal glia-driven neuroinflammation as a therapeutic target for neuropathic pain: rational development of novel analgesics","volume":"179","author":"Zhang","year":"2025","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2026.179294_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107984","article-title":"Wnt signaling: a prospective therapeutic target for chronic pain","volume":"231","author":"Zhou","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2026.179294_bib74","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70360","article-title":"Noradrenergic locus Coeruleus-CA3 activation alleviates neuropathic pain and Anxiety- and depression-like behaviors by suppressing microglial neuroinflammation in SNI mice","volume":"31","author":"Zou","year":"2025","journal-title":"CNS Neurosci. Ther."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926007764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926007764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:05:09Z","timestamp":1789070709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926007764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":74,"alternative-id":["S0014299926007764"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179294","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential modulation of central sensitization pathways by common antipsychotics in a paclitaxel-induced neuropathic pain model","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179294","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"179294"}}